Elisabeth Werner Rönnerman

732 total citations
23 papers, 472 citations indexed

About

Elisabeth Werner Rönnerman is a scholar working on Cancer Research, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Elisabeth Werner Rönnerman has authored 23 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 11 papers in Molecular Biology and 7 papers in Reproductive Medicine. Recurrent topics in Elisabeth Werner Rönnerman's work include Ovarian cancer diagnosis and treatment (7 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Genomics and Diagnostics (4 papers). Elisabeth Werner Rönnerman is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Genomics and Diagnostics (4 papers). Elisabeth Werner Rönnerman collaborates with scholars based in Sweden, United States and Jordan. Elisabeth Werner Rönnerman's co-authors include Anikó Kovács, Per Karlsson, Khalil Helou, Toshima Z. Parris, Hanna Engqvist, Jana Biermann, Eva Forssell‐Aronsson, Peter Larsson, Linda Hartman and Erik Holmberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Elisabeth Werner Rönnerman

22 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabeth Werner Rönnerman Sweden	11	200	161	160	73	44	23	472
Maria Serena Roca Italy	14	457 2.3×	184 1.1×	152 0.9×	104 1.4×	32 0.7×	28	709
Srilakshmi Srinivasan Australia	13	192 1.0×	98 0.6×	101 0.6×	100 1.4×	18 0.4×	23	440
Alexandria Haslehurst Canada	4	291 1.5×	212 1.3×	146 0.9×	47 0.6×	31 0.7×	4	473
Jamie Arnott United States	8	202 1.0×	144 0.9×	86 0.5×	45 0.6×	31 0.7×	21	442
Hend Ahmed El-Hadaad Egypt	9	241 1.2×	243 1.5×	140 0.9×	105 1.4×	36 0.8×	25	552
Francesco Ciccarese Italy	13	436 2.2×	117 0.7×	260 1.6×	98 1.3×	35 0.8×	17	694
Luca Ricotti Italy	11	189 0.9×	226 1.4×	81 0.5×	102 1.4×	35 0.8×	22	440
Denise C. Hegan United States	14	415 2.1×	193 1.2×	123 0.8×	59 0.8×	81 1.8×	19	601
Vaidotas Stankevičius Lithuania	13	400 2.0×	196 1.2×	249 1.6×	104 1.4×	51 1.2×	22	632
Kaushlendra Tripathi United States	17	521 2.6×	223 1.4×	118 0.7×	50 0.7×	25 0.6×	31	718

Countries citing papers authored by Elisabeth Werner Rönnerman

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Werner Rönnerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Werner Rönnerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Werner Rönnerman more than expected).

Fields of papers citing papers by Elisabeth Werner Rönnerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Werner Rönnerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Werner Rönnerman. The network helps show where Elisabeth Werner Rönnerman may publish in the future.

Co-authorship network of co-authors of Elisabeth Werner Rönnerman

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Werner Rönnerman. A scholar is included among the top collaborators of Elisabeth Werner Rönnerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Werner Rönnerman. Elisabeth Werner Rönnerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rönnerman, Elisabeth Werner, Pernilla Dahm‐Kähler, Per Karlsson, et al.. (2025). Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics. PubMed. 33(3). 201019–201019. 1 indexed citations

Werner, Lillian, Elisabeth Werner Rönnerman, Pernilla Dahm‐Kähler, et al.. (2025). Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma. Journal of Ovarian Research. 18(1). 103–103. 1 indexed citations

Werner, Lillian, Elisabeth Werner Rönnerman, Constantina Mateoiu, et al.. (2025). Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer. Scientific Reports. 15(1). 37171–37171.

Saed, Ghassan M., Nicole M. Fletcher, Toshima Z. Parris, et al.. (2024). Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer. SHILAP Revista de lepidopterología. 32(3). 200864–200864. 1 indexed citations

Rönnerman, Elisabeth Werner, Szilárd Nemes, Pernilla Dahm‐Kähler, et al.. (2023). Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma. Frontiers in Oncology. 12. 1112152–1112152. 3 indexed citations

Larsson, Peter, Hanna Engqvist, Elisabeth Werner Rönnerman, et al.. (2022). Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types. BMC Cancer. 22(1). 993–993. 6 indexed citations

Andersson, Carola, Elisabeth Werner Rönnerman, Anikó Kovács, et al.. (2021). Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors. Scientific Reports. 11(1). 23548–23548. 9 indexed citations

Klint, Leif, Anikó Kovács, Elisabeth Werner Rönnerman, & Barbro Linderholm. (2021). Real world data on adjuvant treatment of older HER2-positive breast cancer patients – A single institution experience through 8 years. Cancer Treatment and Research Communications. 28. 100430–100430. 2 indexed citations

Engqvist, Hanna, Toshima Z. Parris, Anikó Kovács, et al.. (2020). Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry. Frontiers in Oncology. 10. 162–162. 28 indexed citations

10.

Engqvist, Hanna, Toshima Z. Parris, Jana Biermann, et al.. (2020). Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes. Scientific Reports. 10(1). 7946–7946. 16 indexed citations

11.

Rönnerman, Elisabeth Werner, et al.. (2020). Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years. The Breast. 50. 113–124. 10 indexed citations

12.

Larsson, Peter, Hanna Engqvist, Jana Biermann, et al.. (2020). Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens. Scientific Reports. 10(1). 5798–5798. 153 indexed citations

13.

Biermann, Jana, Szilárd Nemes, Toshima Z. Parris, et al.. (2019). A 17-marker panel for global genomic instability in breast cancer. Genomics. 112(2). 1151–1161. 9 indexed citations

14.

Kovács, Anikó, Elisabeth Werner Rönnerman, Erik Holmberg, et al.. (2019). Effect of Radiotherapy After Breast-Conserving Surgery Depending on the Presence of Tumor-Infiltrating Lymphocytes: A Long-Term Follow-Up of the SweBCG91RT Randomized Trial. Journal of Clinical Oncology. 37(14). 1179–1187. 44 indexed citations

15.

Engqvist, Hanna, Toshima Z. Parris, Anikó Kovács, et al.. (2019). Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas. BMC Cancer. 19(1). 928–928. 40 indexed citations

16.

Engqvist, Hanna, Toshima Z. Parris, Elisabeth Werner Rönnerman, et al.. (2018). Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival. Oncotarget. 9(80). 35162–35180. 12 indexed citations

17.

Biermann, Jana, Toshima Z. Parris, Szilárd Nemes, et al.. (2018). Clonal relatedness in tumour pairs of breast cancer patients. Breast Cancer Research. 20(1). 96–96. 13 indexed citations

18.

Parris, Toshima Z., Elisabeth Werner Rönnerman, Hanna Engqvist, et al.. (2018). Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma. Oncotarget. 9(35). 24140–24154. 15 indexed citations

19.

Parris, Toshima Z., et al.. (2017). GATA3 as a putative marker of breast cancer metastasis-A retrospective immunohistochemical study. The Breast Journal. 24(2). 184–188. 10 indexed citations

20.

Biermann, Jana, Szilárd Nemes, Toshima Z. Parris, et al.. (2017). A Novel 18-Marker Panel Predicting Clinical Outcome in Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(11). 1619–1628. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact